To celebrate its 50th anniversary, the British Society of for Antimicrobial Chemotherapy (BSAC) are inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, GARDP Scientific Director Laura Piddock explores the challenges involved in re-stimulating the antimicrobial drug development market.
Read the viewpoint on the BSAC website here.